Labcorp.
Company Snapshot
Company Overview
LabCorp is a globally recognized life sciences company dedicated to delivering critical insights that empower physicians, hospitals, pharmaceutical firms, researchers, and patients to make informed and confident decisions.
Operating through its Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD) divisions, the company offers diagnostic services, drug development support, and technology-driven solutions. These services collectively facilitate over 160 million patient interactions annually, equating to more than 3 million weekly engagements.
By integrating Invitae’s genetic testing technology, LabCorp will now offer a complete set of colorectal cancer testing for each patient – from testing to diagnosis to treatment.
Financial Highlights (FY 2024)
This information is available for BCC Research members only.
Labcorp. In News
Company's Business Segments
- Diagnostics Laboratories (Dx) : Diagnostics Laboratories (Dx), which includes routine testing and specialty/esoteric testing
- Biopharma Laboratory Services (BLS) : Biopharma Laboratory Services (BLS), consisting of Early Development Research Laboratories and Central Laboratory Services
Applications/End User Industries
- Physicians
- Hospitals
- Health Systems
- Accountable Care Organizations
- Medicare
- Managed Care Organizations
- Endocrinology
- Life-Changing Therapeutics
- Oncology
- Rheumatology
- Weight Loss Management
- Health Wellness
- Advancing Preventive Care
- Neurology
- Neuroimmunology
- Cardiometabolic
- Immunodeficiency
- Transplant
- Hepatitis
